Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Hypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan WysockiHypertension (Dallas, Tex. : 1979)|May 26, 2026
Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE InhibitorRomy Fischer, Jan Wysocki, Luise Hassler, et al.Biorxiv : the Preprint Server for Biology|March 24, 2021
A novel soluble ACE2 protein totally protects from lethal disease caused by SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.Journal of the American Society of Nephrology : JASN|February 2, 2021
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney OrganoidsJan Wysocki, Minghao Ye, Luise Hassler, et al.Thescientificworldjournal|September 6, 2005
Angiotensin II and renal tubular ion transportPatricia Valles, Jan Wysocki, Daniel BatlleClinical Science (London, England : 1979)|November 2, 2020
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discoveryEnrique Lores, Jan Wysocki, Daniel BatlleBiomolecules|December 22, 2019
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin SystemJan Wysocki, Arndt Schulze, Daniel BatlleClinical Science (London, England : 1979)|March 14, 2020
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?Daniel Batlle, Jan Wysocki, Karla SatchellAmerican Journal of Hypertension|May 14, 2015
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III AxisJan Wysocki, Minghao Ye, Daniel BatlleCells|February 9, 2024
Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta VariantCosimo Cianfarini, Luise Hassler, Jan Wysocki, et al.Pageof 13